Verity Asset Management, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verity Asset Management, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,196,042
+29.7%
31,310
+22.5%
0.88%
+28.8%
Q2 2023$922,274
-23.0%
25,569
-18.4%
0.68%
-4.3%
Q1 2023$1,197,371
-20.8%
31,353
+18.0%
0.72%
-44.7%
Q4 2022$1,512,118
-99.9%
26,575
-16.7%
1.29%
-0.6%
Q3 2022$1,260,852,000
+100848.9%
31,888
+1.9%
1.30%
+63.9%
Q1 2022$1,249,000
-13.2%
31,296
-12.6%
0.79%
-6.6%
Q4 2021$1,439,000
+17.0%
35,797
+18.4%
0.85%
+6.6%
Q3 2021$1,230,000
+22.4%
30,241
+36.6%
0.80%
+44.6%
Q2 2021$1,005,000
+24.8%
22,135
+14.6%
0.55%
+14.8%
Q1 2021$805,000
+1.5%
19,310
+4.0%
0.48%
-13.2%
Q4 2020$793,000
+52.8%
18,575
-5.9%
0.55%
+40.0%
Q3 2020$519,000
-12.5%
19,743
-10.7%
0.40%
-27.8%
Q2 2020$593,000
+38.2%
22,106
-7.3%
0.55%
+1.1%
Q1 2020$429,000
-18.6%
23,852
-19.8%
0.54%
+3.0%
Q4 2019$527,000
+10.0%
29,737
-3.7%
0.52%
+4.6%
Q3 2019$479,000
-11.0%
30,871
-1.5%
0.50%
-16.9%
Q2 2019$538,000
+55.0%
31,329
+45.3%
0.60%
+50.6%
Q1 2019$347,000
+16.8%
21,569
+6.2%
0.40%
+0.8%
Q4 2018$297,000
+89.2%
20,313
+24.6%
0.40%
+163.6%
Q4 2014$157,00016,3020.15%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders